Skip to content
Camlin Fine Sciences logo

Camlin Fine Sciences

CAMLINFINE NSE
₹84.05 0.30 (0.36%)
Market Cap
₹1,615 Cr
P/E
289.83

Camlin Fine Sciences (CAMLINFINE) share price was ₹84.05 at the 28 Oct 2026 close; market capitalisation ₹1,615 Cr; P/E (TTM) 289.83; sector Chemicals. The share price fell 56.9% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Jun 2026 quarter, revenue rose 27.5% year on year to ₹519.9 Cr and net profit was −₹34 Cr, against −₹11 Cr a year earlier (compared with Jun 2025). Promoters held 48.03% of Camlin Fine Sciences in Sep 2026, unchanged from Jun 2026. Its Tapetide Score is 30/100 (Poor) as of 28 Oct 2026.

Close 28 Oct 2026 ₹84.05 −110.80 −56.86% 1Y

Key Fundamentals

MicrocapChemicals & PetrochemicalsChemicals
Market Cap
₹1,615 Cr
P/E (TTM)
289.83
EBITDA
₹136 Cr
Return on Equity
-3.15%
Debt to Equity
0.69
Book Value
₹54.01
EPS (TTM)
₹0.29
52W High
₹202.45
52W Low
₹78.80

Price-based figures as of 28 Oct 2026, 15:50 IST · EPS basis: Consolidated · TTM

Peer Comparison

Commodities › Chemicals › Specialty Chemicals

Pidilite Industries
₹1,389.6053.411,41,445 Cr13.071.48%22.36%28.48%15,689 Cr2,677 Cr
Gujarat Fluorochemicals
₹4,267.1077.4746,874 Cr6.000.07%7.25%10.13%5,334 Cr600 Cr
Navin Fluorine International
₹8,501.0055.1843,604 Cr10.980.18%16.70%18.66%3,734 Cr789 Cr
Aether Industries
₹1,588.4089.5921,082 Cr8.580.00%8.94%12.15%1,257 Cr235 Cr
Deepak Nitrite
₹1,488.4025.9220,301 Cr3.480.52%9.38%10.85%8,624 Cr784 Cr
Aarti Industries
₹437.3029.8715,856 Cr2.660.23%7.04%8.53%9,040 Cr531 Cr
Atul
₹5,225.5019.9315,385 Cr2.340.55%10.95%13.54%7,185 Cr788 Cr
Camlin Fine Sciences (this company)
₹84.05289.831,615 Cr1.560.00%-3.15%3.03%1,966 Cr0 Cr
Median 8 companies₹1,538.4054.3020,692 Cr4.740.21%9.16%11.50%6,260 Cr692 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100. How it works →

As of 2026-10-28
v2.0.0
30 Poor
Overall score
Data confidence 98/100

Category scores

Quality Poor 32
Returns, margins, earnings quality 22%
Valuation Poor 26
Cheap vs sector & own history 24%
Growth Average 47
Sales & profit trajectory 9%
Financial Health Poor 22
Solvency, leverage, coverage 9%
Momentum Poor 7
Trend strength, vol-adjusted 12%
Ownership Weak 39
FII/DII/promoter flows 24%

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

1
  • Company's working capital requirements have reduced from 35.3 days to 22.6 days

Weaknesses

4
  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of 7.74% over past five years.
  • Company has a low return on equity of -6.99% over last 3 years.
  • Earnings include an other income of Rs.63.6 Cr.

Technical Indicators

Oscillators

BearishNeutralBullish

Bearish

Bearish
2
Neutral
6
Bullish
1

Overall

BearishNeutralBullish

Bearish

Bearish
12
Neutral
6
Bullish
1

Moving Averages

BearishNeutralBullish

Bearish

Bearish
10
Neutral
0
Bullish
0
Analyst Rating
Based on 2 analysts
TIED50%

1 of 2 analysts rate Buy, 1 Hold, 0 Sell.

Updated 28 Oct 2026

BUY
1
50%
HOLD
1
50%
SELL
0
0%

Growth Rate

Revenue Growth
6.59% higher than 3Y

change over 1 year

Net Income Growth
-148% lower than 3Y

change over 1 year

Cash Flow Change
257%

change over 1 year

EBITDA Margin Change
-44.95%

change over 1 year Operating margin 1.8% · Jun 2026

Analyst Forecasts

Forecast For
FY27 consensus · EBITDA
₹232 Cr +70.9% vs FY26
Reported High Mean Low

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
420
406
386
377
381
417
431
432
408
460
441
425
520
Expenses
381
381
363
345
352
366
375
370
387
427
420
404
511
Operating Profit
39
25
23
31
29
52
56
62
20
33
21
21
9
OPM %
9%
6%
6%
8%
8%
12%
13%
14%
5%
7%
4.7%
5%
1.8%
Other Income
6
2
2
-96
-15
-151
-8
-22
0
-4
-24
103
-10
Interest
10
20
14
16
23
26
34
15
15
19
17
23
14
Depreciation
19
19
21
13
15
17
14
17
16
19
16
21
19
PBT
16
-12
-10
-94
-23
-142
0
8
-11
-9
-37
80
-34
Tax %
25%
72%
47%
-13%
48%
-18%
2164%
98%
0%
65%
0%
-8%
-1%
Net Profit
12
-21
-14
-82
-35
-116
-7
0
-11
-15
-37
86
-34
EPS (₹)
0.83
-1.03
-0.63
-4.11
-1.81
-5.33
-0.22
-0.04
-0.53
-0.76
-1.89
4.59
-1.65
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
558
489
534
721
892
1,049
1,187
1,412
1,682
1,454
1,629
1,723
1,845
Expenses
474
397
502
705
819
914
1,000
1,254
1,471
1,284
1,402
1,605
1,761
Operating Profit
84
92
32
16
73
135
187
158
211
170
227
118
84
OPM %
15%
19%
6%
2.2%
8%
13%
16%
11%
13%
12%
14%
7%
4.6%
Other Income
9
-1
14
12
14
3
5
33
-4
-142
-218
59
64
Interest
24
24
31
32
41
48
42
41
64
70
107
83
73
Depreciation
16
17
22
27
29
33
44
56
63
56
61
71
75
PBT
53
50
-6
-31
17
58
105
94
80
-99
-159
23
0
Tax %
-4%
28%
-26%
-22%
82%
49%
38%
36%
50%
6%
0%
-2%
—
Net Profit
55
36
-4
-24
3
30
65
60
40
-105
-158
24
1
EPS (₹)
5.11
3.3
-0.96
-2.18
0.04
2.23
3.56
3.45
2.96
-4.94
-7.4
1.44
0.29
Div. Payout %
8%
12%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
10
10
10
12
12
12
13
16
16
17
19
19
Reserves
125
167
202
359
359
391
631
732
804
848
883
1,022
Borrowings
160
180
331
373
461
539
550
646
801
683
652
720
Other Liabilities
131
123
126
273
255
290
282
396
425
424
467
559
Total Liabilities
426
479
669
1,016
1,087
1,232
1,475
1,790
2,045
1,972
2,020
2,320
Fixed Assets
106
140
201
278
272
306
584
601
858
816
704
887
CWIP
3
25
8
14
59
179
24
215
43
46
10
33
Investments
1
1
19
115
11
7
7
7
8
8
61
30
Other Assets
316
313
442
609
745
740
861
966
1,136
1,102
1,246
1,370
Total Assets
426
479
669
1,016
1,087
1,232
1,475
1,790
2,045
1,972
2,020
2,320
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
46
72
-9
-15
-9
86
117
145
51
139
23
82
Investing
-26
-66
-70
-149
-2
-90
-133
-249
-125
-66
-75
-53
Financing
-15
-7
91
182
26
3
39
136
60
-86
76
-25
Net Cash Flow
4
-1
13
18
15
-1
23
32
-14
-13
24
4
Free Cash Flow
19
5
-39
-34
-78
-48
34
-68
-93
79
-19
20
CFO/EBITDA
68
91
5
-33
10
77
82
111
34
110
27
90
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
74
56
99
104
86
88
83
77
66
72
74
79
Inventory Days
184
311
277
207
219
204
200
178
255
256
234
199
Days Payable
144
171
110
154
127
119
99
112
129
154
180
200
Cash Conversion Cycle
114
196
266
157
178
173
184
143
192
174
127
78
Working Capital Days
12
1
-6
19
43
22
55
40
42
51
33
23
ROCE %
28%
24%
5%
0%
7%
11%
13%
10%
10%
8%
12%
5%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Camlin Fine Sciences insights

68 extracted metrics + investor summaries across FY07–FY27.

Shareholding Pattern

FIIs0.95%Promot.48.03%DIIs5.32%Others14.94%Public30.76%As ofSep 2026
16.20% of promoter holding pledged as of Sep 2026

Documents

Frequently Asked Questions about Camlin Fine Sciences

What does Camlin Fine Sciences Ltd do?
Camlin Fine Sciences is engaged in the Business of Speciality Chemicals.
Where is Camlin Fine Sciences Ltd (CAMLINFINE) listed?
Camlin Fine Sciences Ltd trades as CAMLINFINE on the NSE and under code 532834 on the BSE.
Which sector does Camlin Fine Sciences Ltd belong to?
Camlin Fine Sciences Ltd is classified under the Chemicals sector, in the Specialty Chemicals industry.
What is the market capitalisation of Camlin Fine Sciences Ltd?
Camlin Fine Sciences Ltd has a market capitalisation of ₹1,615 Cr as of 28 Oct 2026, which places it in the Small Cap band.
What is the PE ratio of Camlin Fine Sciences Ltd?
Camlin Fine Sciences Ltd trades at a PE ratio of 289.83 as of 28 Oct 2026, on earnings per share of ₹0.29, against a book value of ₹54.01 per share.
What is the 52-week high and low of Camlin Fine Sciences Ltd?
Over the last 52 weeks Camlin Fine Sciences Ltd has traded between ₹78.8 and ₹202.45 as of 28 Oct 2026.
What is the Return on Equity (ROE) of Camlin Fine Sciences Ltd?
Camlin Fine Sciences Ltd reported a return on equity of -3.15%. Its debt-to-equity ratio is 0.69.

Company Information

Camlin Fine Sciences is engaged in the Business of Speciality Chemicals.

Website camlinfs.com
CEO Mr. Ashish Subhash Dandekar
Employees 661
Listed 2007-03-30
Face Value ₹ 1
Shares Outstanding 19,20,96,613

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/CAMLINFINE.md for Camlin Fine Sciences Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Chemical & Petrochemical stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month